
    
      The study duration per subject will be 26 to 83 days and will consist of a screening period
      of 2-28 days, a treatment period of 6 days each for Periods 1, 2 and 3, a washout between
      treatment periods of 1-14 days, and follow up visit 10-15 days after the last Investigational
      Medicinal Product administration in period 3.
    
  